Meeting
2019 ASCO Annual Meeting
Clinical and economic outcomes of pegfilgrastim in metastatic colorectal cancer.
Authors
Lalan S. Wilfong
Texas Oncology, Dallas, TX
Lalan S. Wilfong , Jody S. Garey , Bo He , Jad Hayes , Hope Ives , Susan Nga Hoang , Marcus A. Neubauer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 37, 2019 (suppl; abstr 6636)
DOI
10.1200/JCO.2019.37.15_suppl.6636
Abstract #
6636
Poster Bd #
327
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Quality Care Symposium
A budget impact model for biosimilar myeloid growth factors (MGFs) within the Oncology Care Model (OCM): An oncology group practice perspective.
First Author: Ali McBride
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world comparison of low- versus high-dose continuous 5FU infusion in patients receiving triplet chemotherapy plus bevacizumab for newly diagnosed metastatic colorectal cancer (mCRC).
First Author: William Joseph Chapin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Serum angiopoietin-like protein 2 level in patients who received bevacizumab-containing chemotherapy for metastatic colorectal cancer.
First Author: Jung Hoon Kim
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Impact of early tumor shrinkage and depth of response in patients with BRAF V600E-mutant metastatic colorectal cancer.
First Author: Shohei Udagawa